| EFX |
Report |
Adjusted EPS (Q2 2026) |
BEAT |
pred ~$2.24 vs. cons ~$2.20 |
MEDIUM |
| EFX |
Report |
Total revenue (Q2 2026) |
IN-LINE |
pred ~$1.70B vs. cons ~$1.69B |
MEDIUM |
| EFX |
Report |
U.S. mortgage revenue growth (the stock-mover, given hawkish rate turn) |
MISS |
pred ~+17% vs. cons ~+21% |
MEDIUM |
| EFX |
Guide |
FY2026 adjusted EPS guide |
UNCHANGED |
guide ~$8.34-8.74 (mid $8.54) vs. cons ~$8.55 (FY2026); market wanted a raise |
MEDIUM |
| EFX |
Guide |
FY2026 revenue guide |
UNCHANGED |
guide ~$6.70-6.80B (mid $6.75B) vs. cons ~$6.78B (FY2026); maintained not raised |
MEDIUM |
| EFX |
Guide |
Q3 2026 revenue guide |
LOWER |
guide ~$1.74B vs. cons ~$1.77B (Q3 2026) |
LOW |
| EFX |
Guide |
Q3 2026 adjusted EPS guide |
LOWER |
guide ~$2.28 vs. cons ~$2.33 (Q3 2026) |
LOW |
| EFX |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.0% |
— |
MEDIUM |
| EFX |
Return |
5-day cumulative residual |
-4.5% (FOLLOW-THROUGH) |
Repeat of the last two 'sell-the-beat' prints: a modest headline beat but guidance only maintained (not raised) against a hawkish rate backdrop with mortgage tracking below the >20% framework. Out-period math forces implicit cuts — Q3/FY sell-side estimates drift down even after the Q2 beat — so the initial negative reaction extends rather than reverses. Only a VantageScore/FHFA activation surprise or clearly constructive May-June mortgage run-rate commentary would stabilize it; base case is continued downward drift. |
LOW |